The Chronic GvHD Landscape: Risk Factors and Diagnosis
Preet M. Chaudhary, MD, PhD and Noah Merin, MD, PhD review how chronic GvHD is diagnosed, the different types of chronic GvHD, and key risk factors for the disease.
Stay updated with breaking news from Agvhd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Preet M. Chaudhary, MD, PhD and Noah Merin, MD, PhD review how chronic GvHD is diagnosed, the different types of chronic GvHD, and key risk factors for the disease.
Expert clinicians discuss first-line treatment methodologies for chronic GvHD, with a focus on tailoring treatments to the patient.
Panelists Hannah Choe, MD, and Bart L Scott, MD share insights concerning prophylaxis in Graft-Versus-Host Disease, including key study data and current standards of care as well as discuss the potential role of biomarkers in GvHD.
A young man has revealed the symptoms that led to his devastating diagnosis blood cancer diagnosis.
Patent will allow the development of an industrial biomarker analysis kit which could be available worldwide - News - PharmaTimes